iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionSumitomo Mitsui Financial Group, Inc.
Latest Disclosed Ownership4,938 shares
Latest Disclosed Value $ 833,781
Sumitomo Mitsui Financial Group, Inc. reports 0.75% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 14, 2026 - Sumitomo Mitsui Financial Group, Inc. filed a 13F-HR form disclosing ownership of 4,938 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $833,781 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 4,901 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.75% during the quarter. The current value of the position is $647,125 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,938 37 0.75 834 0.73 0.0165
2026-02-12 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,901 -2,026 -29.25 827 -17.30 0.0146
2025-11-12 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,927 -570 -7.60 1,000 5.49 0.0175
2025-08-13 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 7,497 1,436 23.69 948 22.32 0.0154
2025-05-14 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,061 -637 -9.51 775 -12.43 0.0142
2025-02-13 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,698 -334 -4.75 886 -13.49 0.0118
2024-11-08 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 7,032 -507 -6.73 1,024 -1.06 0.0264
2024-08-13 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 7,539 -392 -4.94 1,035 -4.96 0.0322
2024-05-13 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 7,931 -1,366 -14.69 1,088 -13.79 0.0337
2024-02-08 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 9,297 -5,732 -38.14 1,263 -31.30 0.0400
2023-11-08 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 15,029 289 1.96 1,838 -1.82 0.0592
2023-08-09 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 14,740 -720 -4.66 1,871 -6.26 0.0595
2023-05-11 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 15,460 -84 -0.54 1,997 -2.16 0.0626
2023-02-10 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 15,544 -321 -2.02 2,041 9.91 0.0772
2022-11-08 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 15,865 -3,600 -18.49 1,856 -18.95 0.0781
2022-08-09 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 19,465 -4,878 -20.04 2,290 -27.81 0.0643
2022-05-12 2022-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 24,343 -1,110 -4.36 3,172 -18.35 0.0930
2022-02-10 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 25,453 1,486 6.20 3,885 0.26 0.1116
2021-11-10 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 23,967 -990 -3.97 3,875 -5.12 0.0885
2021-08-11 2021-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 24,957 6,322 33.93 4,084 45.55 0.0899
2021-05-13 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 18,635 3,620 24.11 2,806 23.34 0.0662
2021-02-12 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 15,015 -316 -2.06 2,275 9.59 0.0560
2020-11-12 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 15,331 6,431 72.26 2,076 70.58 0.0709
2020-08-14 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 8,900 3,983 81.00 1,217 129.62 0.0418
2020-05-14 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 4,917 198 4.20 530 -6.85 0.0261
2020-02-14 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 4,719 1,400 42.18 569 72.42 0.0447
2019-11-08 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,319 612 22.61 330 11.86 0.0273
2019-08-09 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,707 -2,817 -51.00 295 -52.27 0.0233
2019-05-14 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 5,524 -5,124 -48.12 618 -38.81 0.0552
2019-02-08 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 10,648 -640 -5.67 1,010 -26.60 0.0639
2018-11-09 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 11,288 -3,874 -25.55 1,376 -17.36 0.1119
2018-08-14 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 15,162 -141 -0.92 1,665 1.96 0.1706
2018-05-14 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 15,303 11,994 362.47 1,633 362.61 0.1504
2018-02-13 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,309 3,309 353 0.0462
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.